o-Methoxy-sila-hexocyclium: a new quaternary M\(_1\)-selective muscarinic antagonist by Lambrecht, G. et al.
European Journal of Pharmaco/ogy, 151 (1988) 155-156 
Elsevier 
EJP 0130R 
155 
Rapid communication 
o-Methoxy-sila-hexocyclium: 
a new quatemary M 1-selective muscarinic antagonist 
Günter Lambrecht *, Gernot Gmelin 1, Klaus Rafeiner 2 , Carsten Strohmann 2 , 
Reinhold Tacke 2 and Ernst Mutschier 
Department of Pharmacology, University of Frankfurt, D-6000 Frankfurt/ M, F. R. G., 1 Sandoz Ltd, CH-4002 Basel, Switzerland, 
and 1 Institute of Inorganic and Analytical Chemistry, Technica/ University of Braunschweig, D-3300 Braunschweig, FR. G. 
Received 17 May 1988, accepted 19 May 1988 
The musearlnie receptors are currently divided 
into at least three subtypes: M1, M 2a and M 2ß 
(for recent reviews, see Eglen and Whiting, 1986; 
Mutschier et al., 1987; 1988). M1-Receptors are 
found in high density in neuronal tissues such as 
autonomic ganglia, cerebral cortex and hippo-
campus, whereas M 2-receptors are mainly present 
in lower brain areas and in peripheral effector 
organs such as heart (M 2a) and smooth musdes 
(M 2ß) as weil as glands (M 2ß). Their different 
affinities for selective muscarinic antagonists such 
as pirenzepine (M1 >> M 2a = M 2ß; Hammer and 
Giachetti, 1982; Mutschier et al., 1987; 1988) and 
methoctramine (M 2 a > M 1 > M 2ß; Mutschier et 
al., 1988) are a major characteristic of these sub-
types. Recent structure-selectivity relationship 
sturlies of a series of difenidol and hexocyclium 
analogues have led to the discovery of novel 
muscarinic antagonists, hexahydro-sila-difenidol 
(M1 = M2ß >> M 2 a) and sila-hexocyclium (SiHC; 
M1 ::::: M 2ß > M 2a) (Mutschler et al., 1987; 1988), 
which display a high selectivity in blocking smooth 
muscle and glandular M 2ß-receptors in compari-
son to cardiac M 2a-receptors. We report here on 
the unique pharmacological profile of o-methoxy-
sila-hexocyclium (o-MeSiHC; 4-{[cyclohexylhy-
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droxy(2-methoxyphenyl)silyl]methyl} -1, 1-dimeth-
ylpiperazinium methyl sulfate) which ex.hibits a 
spectrum of selectivity different from that of the 
parent compound (SiHC). To the best of our 
knowledge, o-MeSiHC is the first quaternary anti-
muscarinic agent which shows high M1-receptor 
selectivity. 
Experiments on ganglia were performed as de-
scribed by Brown et al. (1980). Briefly, superior 
cervical ganglia were isolated from rats anaesthe-
tised with urethane. The ganglia were suspended 
in separate heated chambers (36 ° C) and super-
fused with oxygenated (5% C02 , 95% 0 2 ) Krebs 
solution (composition in mmoljl: NaC1124; KCl 
3; NaHC03 26; NaH 2P04 1.25; CaC1 2 2; MgC1 2 
2; ( + )-glucose 10). Muscarine-induced (pD2 = 7.4) 
depolarisation was recorded differentially, via 
calomel electrodes, between the ganglion and its 
postganglionic trunk. Semicumulative dose-re-
sponse curves for muscarine were obtained and 
the antagonists pirenzepine and o-MeSiHC were 
pre-equilibrated for 30 min. Left atria and strips 
of ileallongitudinal muscle from adult guinea-pigs 
were incubated under 0.5 g tension in 6 ml 
oxygenated (5% C02 , 95% 0 2 ) Tyrode solution 
(32°C; composition in mmoljl: NaCl 137; KCI 
2.7; CaC1 2 1.8; MgC1 2 1.05; NaHC03 11.9; 
NaH 2 P04 0.42; ( + )-glucose 5.6). The atria were 
paced electrically at 120 beatsjmin. The ileum 
contractions and negative inotropic responses of 
the atria were recorded with a force-displacement 
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TABLE 1 
Comparison of the pA 2 values for pirenzepine (Pz) and o-
methoxy-sila-hexocyclium (o-MeSiHC) at muscarinic M1-re-
ceptors of rat superior cervical ganglia and at M rreceptors of 
guinea-pig ileum (M 2p) and atria (M 2a). Dose-response curves 
to muscarine (ganglia) and arecaidine propargyl ester (ileum 
and atria) were obtained and dose ratios were estimated for 
antagonist-induced parallel shifts in these curves. pA 2 values 
were determined from Schild plots constrained to slope -1.0. 
The experimental data generated regression lines whose de-
rived slopes were not signifieantly different from unity. The 
results are presented as means ± S.E.M. of 9-12 experiments on 
eaeh preparation. 
pA2 
Ganglia Ileum Atria 
Pz 8.30±0.05 6.88±0.04 6.82±0.03 
o-MeSiHC 8.31 ±0.06 6.96±0.03 6.41 ±0.01 
transducer on a Helcoscriptor. Cumulative dose-
response curves to arecaidine propargyl ester 
(pD2-atria = 8.1; pD2-ileum = 7.5) (Mutschler et 
al., 1988) were obtained before and after the ad-
di tion of an antagonist which was allowed to 
equilibrate for 30 min. At least three concentra-
tions of antagonists were tested in the three tissues 
and dose ratios were estimated for antagonist-in-
duced parallel shifts in the agonist dose-response 
curves. Schild plots were made, using linear re-
gression, by the method of least squares. The 
slopes of these plots were not significantly differ-
ent from unity. The pA 2 values (table 1) were 
estimated by fitting to the data the best straight 
line with a slope equal to unity. 
Pirenzepine and o-MeSiHC proved tobe com-
petitive antagonists at ganglionic M1-, cardiac 
M 2 a- and ileal M2 ß-receptors. Different selectivity 
pattems were observed; pirenzepine: M1 >> M 2 a 
= M 2ß, o-MeSiHC: M1 >> M 2ß > M 2a. A 24-fold 
difference in pA 2 value was determined for both 
antagonists on the rat superior cervical ganglion 
(8.3. This value was very close to the pA 2 value of 
8.36 for pirenzepine determined by Brown et al. 
(1980)) compared with the ileum (6.9). Pirenzepine 
exhibited similar affinities for cardiac M2a- and 
ileal M2ß-receptors. In contrast, the affinity ob-
tained for o-MeSiHC was significantly lower at 
M 2a-receptors in atria than at M 2ß-receptors in 
the ileum. Thus, the selectivity of pirenzepine and 
o-MeSiHC for M1- over M 2a-receptors is 30- and 
78-fold, respectively. 
In conclusion, o-MeSiHC is a potent M1-selec-
tive muscarinic antagonist and could be a useful 
new tool to further investigate muscarinic receptor 
heterogeneity. o-MeSiHC is the first quaternary 
ammonium compound with high M1-receptor 
selectivi ty. I t has the advantage over pirenzepine 
that its selectivity for M1- over M2 a-receptors is 
higher. 
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